My career has been shaped by a fascination for innovation and product development and how businesses succeed or fail to use these to grow successfully in an increasingly global and competitive world. An engineer by training, my fascination was born as a production engineer and project manager in naval shipbuilding, seeing remarkably complex frigates being designed and built.
Following an MBA at INSEAD, I joined PRTM, a firm of operations management consultants that specialised in product development. At PRTM I led major change programmes for many well-known tech companies, involving more than 20 new products, and resulting in dramatically shortened time-to-market and higher new product revenues and profitability.
I then founded my own consultancy firm, Mainstay Innovation Management, working with universities and young tech companies to help overcome the particular challenges of breaking into markets with new products, limited resources and no established "brand value".
In 2010, I co-founded and became CEO of a medtech business, VueKlar Cardiovascular. We successfully built the business, completing two seed funding rounds, and latterly agreed terms with an acquirer that was forced to abandon its expansion plan. Having failed to raise a multi-million pound 'A' round, we sold the business assets and voluntarily wound up the company.
I continue to develop new medtech ventures, the latest being Invizius, a spinout from Edinburgh University.
My career has been shaped by a fascination for innovation and product development and how businesses succeed or fail to use these to grow successfully in an increasingly global and competitive world. An engineer by training, my fascination was born as a production engineer and project manager in naval shipbuilding, seeing remarkably complex frigates being designed and built.
Following an MBA at INSEAD, I joined PRTM, a firm of operations management consultants that specialised in product development. At PRTM I led major change programmes for many well-known tech companies, involving more than 20 new products, and resulting in dramatically shortened time-to-market and higher new product revenues and profitability.
I then founded my own consultancy firm, Mainstay Innovation Management, working with universities and young tech companies to help overcome the particular challenges of breaking into markets with new products, limited resources and no established "brand value".
In 2010, I co-founded and became CEO of a medtech business, VueKlar Cardiovascular. We successfully built the business, completing two seed funding rounds, and latterly agreed terms with an acquirer that was forced to abandon its expansion plan. Having failed to raise a multi-million pound 'A' round, we sold the business assets and voluntarily wound up the company.
I continue to develop new medtech ventures, the latest being Invizius, a spinout from Edinburgh University.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy